Charles River Laboratories Intl. Inc vs Open Text Corporation — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while Open Text Corporation trades at $23.7 (market cap $5.61B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 2.5× Open Text Corporation's market cap, and Open Text Corporation pays a 4.82% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Open Text Corporation for 23 Days on average.
| CRL | OTEX | |
|---|---|---|
Market Cap | $14.23B | $5.61B |
Volume | 1,176,885 | 1,197,475 |
Sector | Health | Technology |
52-Week High | $310.77 | $39.69 |
52-Week Low | $149.93 | $20.01 |
Typical Hold Time | 33 Days | 23 Days |
Enterprise Value | $17.06B | $10.63B |
Dividend Yield | — | 4.82% |
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $298.00, down 0.77% on the day, with a bullish technical signal supported by moving averages. The company has beaten earnings estimates for three consecutive quarters, though it reported a net loss of -$144.34M for 2025. Analyst consensus is strongly positive with a $305.50 price target, and recent news highlights a strategic growth plan targeting 5%-7% revenue growth by 2030.
The stock's outlook is supported by strong analyst buy ratings and a clear growth strategy, but faces risks from negative profitability metrics and high valuation multiples. Investment opportunity hinges on successful execution of margin expansion and cost savings initiatives, while key risks include persistent net losses and competitive pressures in the healthcare services sector.
OpenText (OTEX) trades at $23.24, up 0.43% on the day, with a bearish technical signal from moving averages and a neutral oscillator stance. The stock shows strong fundamentals, including a low P/E of 9.01 and robust profitability with a net income margin of 12.26%. Recent earnings beats and a strategic AI partnership with Cohere highlight positive momentum, while active debt management through note offerings and tender offers aims to optimize the balance sheet.
The outlook for OTEX is cautiously optimistic, supported by valuation discounts and improving cloud performance, but risks include high debt levels and competitive pressures. Analyst consensus leans toward a buy with a $28.30 price target, suggesting potential upside if execution continues.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →